Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.
de Mendoza
C
C
Service of Infectious Diseases, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
Soriano
V
V
González-Lahoz
J
J
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage; D006801:Humans; D008297:Male; D012367:RNA, Viral / Q000032:analysis / Q000187:drug effects*; D012189:Retrospective Studies; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D014779:Virus Replication / Q000187:drug effects*
D019380:Anti-HIV Agents; D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D012367:RNA, Viral